🕵️ Stoke Therapeutics Inc ($STOK)
SEC insider & ownership activity, last 12 months · CIK 1623526 · every row links its SEC filing
Over the last 12 months insiders sold $12.4M with no open-market buying against it. Kaye Edward M. Md sold $4.2M through a 10b5-1 trading plan in 18 lots (Aug–Dec). Blackrock, Inc. added 5.8% → 6.8%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 8 sellers, $12.4M (87 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Kaye Edward M. Md | 0 | – | 18 | $4.2M | Dec 8, 2025 |
| Adrian R. Krainer | 0 | – | 5 | $3.9M | Mar 10, 2026 |
| Jonathan D Allan | 0 | – | 25 | $2.1M | Jun 16, 2026 |
| Baruch S. Ticho | 0 | – | 27 | $1.7M | Jul 1, 2026 |
| Tzianabos Arthur | 0 | – | 1 | $174K | Mar 10, 2026 |
| Leggett Thomas | 0 | – | 5 | $147K | Mar 18, 2026 |
| Hoitt Jason | 0 | – | 5 | $119K | Mar 18, 2026 |
| Arthur A. Levin | 0 | – | 1 | $22K | Mar 13, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Montrago (trustee) | 13.0% | 13D | Dec 23, 2024 | filing ↗ | |
| Skorpios Trust | 13.0% | 13D | Dec 23, 2024 | filing ↗ | |
| Roderick WONG, M.D. | 10.0% | 13G | Feb 14, 2025 | filing ↗ | |
| RTW Investments, LP | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Roderick Wong | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| FMR LLC | 9.8% | 13G | Feb 5, 2026 | filing ↗ | |
| Abigail P. Johnson | 9.8% | 13G | Feb 5, 2026 | filing ↗ | |
| LYNX1 Capital Management LP | 8.1% | 13G | May 18, 2026 | filing ↗ | |
| Weston Nichols | 8.1% | 13G | May 18, 2026 | filing ↗ | |
| Ezbon International Limited | 7.4% | 13D | Dec 23, 2024 | filing ↗ | |
| Blackrock, Inc. | 6.8% | 13G | Oct 17, 2025 | filing ↗ | |
| Redmile Group, LLC | 6.7% | 13G | May 15, 2026 | filing ↗ | |
| Jeremy C. Green | 6.7% | 13G | May 15, 2026 | filing ↗ | |
| Morgan Stanley | 6.5% | 13G | Feb 3, 2025 | filing ↗ | |
| Baker BROS. Advisors LP | 5.8% | 13G | Feb 17, 2026 | filing ↗ | |
| Baker BROS. Advisors (GP) LLC | 5.8% | 13G | Feb 17, 2026 | filing ↗ | |
| Julian C. Baker | 5.8% | 13G | Feb 17, 2026 | filing ↗ | |
| Felix J. Baker | 5.8% | 13G | Feb 17, 2026 | filing ↗ | |
| The Toronto-Dominion Bank | 5.8% | 13G | Nov 14, 2025 | filing ↗ | |
| Blue Horizon Enterprise Ltd. | 5.6% | 13D | Dec 23, 2024 | filing ↗ | |
| Redmile Biopharma Investments III, L.P. | 5.6% | 13G | May 15, 2026 | filing ↗ | |
| The Toronto-Dominion Bank | 5.4% | 13G | May 15, 2026 | filing ↗ | |
| Morgan Stanley Capital Services LLC | 5.4% | 13G | Feb 3, 2025 | filing ↗ | |
| Wellington Management Group LLP | 5.2% | 13G | May 15, 2026 | filing ↗ | |
| Wellington Group Holdings LLP | 5.2% | 13G | May 15, 2026 | filing ↗ | |
| Wellington Investment Advisors Holdings LLP | 5.2% | 13G | May 15, 2026 | filing ↗ | |
| Wellington Management Company LLP | 5.1% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Baruch S. Ticho | $237K | Jul 1, 2026 | filing ↗ |
| Jonathan D Allan | $44K | Jun 16, 2026 | filing ↗ |
| Baruch S. Ticho | $132K | May 1, 2026 | filing ↗ |
| Baruch S. Ticho | $60K | Apr 1, 2026 | filing ↗ |
| Jonathan Allan | $308K | Mar 20, 2026 | filing ↗ |
| Baruch S. Ticho | $45K | Mar 19, 2026 | filing ↗ |
| Arthur A Levin | $22K | Mar 13, 2026 | filing ↗ |
| Arthur Tzianabos | $3.5M | Mar 10, 2026 | filing ↗ |
| Adrian Krainer | $1.5M | Mar 2, 2026 | filing ↗ |
| Edward M Kaye | $415K | Dec 8, 2025 | filing ↗ |
| Jonathan Allan | $123K | Dec 8, 2025 | filing ↗ |
| Edward M Kaye | $68K | Dec 5, 2025 | filing ↗ |
| Jonathan Allan | $242K | Dec 5, 2025 | filing ↗ |
| Baruch Ticho | $62K | Dec 5, 2025 | filing ↗ |
| Adrian Krainer | $1.2M | Nov 24, 2025 | filing ↗ |
| Adrian Krainer | $1.1M | Nov 14, 2025 | filing ↗ |
| Baruch Ticho | $178K | Nov 3, 2025 | filing ↗ |
| Edward M Kaye | $683K | Oct 8, 2025 | filing ↗ |
| Edward M Kaye | $1.1M | Oct 3, 2025 | filing ↗ |
| Jonathan Allan | $248K | Oct 3, 2025 | filing ↗ |
| Baruch Ticho | $214K | Sep 2, 2025 | filing ↗ |
| Edward M Kaye | $1.2M | Aug 29, 2025 | filing ↗ |
| Jonathan Allan | $437K | Aug 29, 2025 | filing ↗ |
| Jonathan Allan | $186K | Aug 13, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jun 30, 2026 | filing ↗ |
| Other events (8.01) | Jun 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 30, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 3, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 3, 2026 | filing ↗ |
| Auditor change (4.01) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 13, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 21, 2026 | filing ↗ |
| New financial obligation (2.03) | Jan 21, 2026 | filing ↗ |
| Earnings (2.02) | Jan 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 11, 2026 | filing ↗ |
| Other events (8.01) | Jan 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 5, 2025 | filing ↗ |
| Other events (8.01) | Dec 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 5, 2025 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 5, 2025 | filing ↗ |
| Earnings (2.02) | Aug 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2025 | filing ↗ |